{"id":"W2805806091","doi":"10.1016/j.cgh.2018.05.026","title":"Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases","year":2018,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"Takeda Pharmaceutical Company; Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Internal medicine; Placebo; Ulcerative colitis; Gastroenterology; Inflammatory bowel disease; Post-hoc analysis; Crohn's disease; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004781231,0.0002708748,0.0003811928,0.0001226008,0.00009743495,0.00001040201,0.0002655647,0.0003435222,0.00005902423],"category_scores_gemma":[0.0004335594,0.0002193135,0.0000928403,0.00005329708,0.001223296,0.000007981717,0.0002334887,0.0002050495,0.00004330352],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000164314,"about_ca_system_score_gemma":0.0001224374,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002585285,"about_ca_topic_score_gemma":0.0001922652,"domain_scores_codex":[0.9968845,0.001184671,0.0005478312,0.0007441597,0.00007755058,0.0005613494],"domain_scores_gemma":[0.998782,0.0001130671,0.0001478843,0.000471291,0.0001619974,0.0003237728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08608032,0.0003249647,0.9109868,0.000005652101,0.00007308933,0.000102356,0.00003392989,0.000001184606,0.0002511129,0.00001991716,0.0008428681,0.001277763],"study_design_scores_gemma":[0.005649281,0.01058002,0.9785595,0.00001060431,0.0000169821,0.00001417807,0.00002111143,0.00001052571,0.00004057561,0.0000487578,0.004882664,0.0001657965],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984832,0.0001039371,0.00006114581,0.0004849793,0.0003055611,0.0004535291,0.00004884412,0.0000242082,0.00003456785],"genre_scores_gemma":[0.9926519,0.0001559551,0.0001639316,0.006610715,0.0002225829,0.00008046678,0.00006455508,0.00002501828,0.00002486114],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08043104,"threshold_uncertainty_score":0.8943344,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01319386288923481,"score_gpt":0.2789419544049325,"score_spread":0.2657480915156977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}